drugset / Trial / NCT01449591
Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the safety, tolerability and efficacy of BFH772 after 12 weeks of treatment as compared to an active control and vehicle in patients with erythemato-telangiectatic rosacea.
Timeline
- Start
- 2011-09
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BFH772 | Small molecule | 1 % | — |
| Comparator | Metronidazole | Small molecule | 1 % | — |